TGen, the Translational Genomics Research Institute, is a nonprofit medical research institute based in Arizona, dedicated to advancing the understanding of complex diseases through innovative genomic research. The institute focuses on unraveling the genetic components of various conditions, including cancer, neurological disorders, infectious diseases, and rare childhood disorders. By employing advanced genomic techniques, TGen aims to identify personalized treatment options that enhance the precision and effectiveness of medical care. Their commitment to early detection and smarter treatments is evident in their initiatives, such as the Relentless Pursuit Initiative, which honors Dr. Daniel D. Von Hoff and supports pancreatic cancer research.

In addition to its research efforts, TGen actively engages the community through programs like the TGen Bioscience Leadership Academy, which educates high school students about biosciences and precision medicine. This program not only provides students with hands-on experience in laboratory settings but also emphasizes the development of essential STEM skills, including science communication and networking. TGen's collaborations with various organizations, such as the Longevity Consortium and the Soteria Precision Medicine Foundation, further illustrate its commitment to integrating cutting-edge research with practical applications in patient care, ultimately striving to improve health outcomes for individuals facing serious medical challenges.

United States

TGen, an affiliate of City of Hope, is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments.

Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics and treatments for cancer, neurological disorders, rare childhood disorders, infectious disease and other complex conditions.

Stay up-to-date: tgen.org/subscribe

TGen

Company Details